Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 and June 3 was host to the Poster Session: Genitourinary Cancer - Kidney and ...

PYC Therapeutics has concluded the first cohort dosing of healthy volunteers in the Phase Ia SAD trial of its drug candidate ...

PARP inhibitors demonstrate synergy with radiation, so investigators tested the efficacy and safety of olaparib plus radium-223 in patients with mCRPC and bone metastases in a phase 2 trial.

The next-generation KRAS G12C inhibitor MK-1084 showed promising efficacy and safety as a single agent and in combinations ...

In this Woman's Doctor segment, breast cancer treatment can be grueling, and it can also make for long days. A new study shows higher doses of radiation given over fewer sessions was as effective as ...

A new study shows higher doses of radiation given over fewer sessions for breast cancer was as effective as being given lower ...

Merck & Co. has posted phase 2 data on zilovertamab vedotin in lymphoma, providing more evidence of the narrow safety and ...

Verve Therapeutics, in an official release, noted that the initial results of the VERVE-102 clinical trial demonstrated no ...